{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:57:34Z","timestamp":1790855854296,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00277-018-3296-7","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T14:46:36Z","timestamp":1521125196000},"page":"1259-1269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw"],"prefix":"10.1007","volume":"97","author":[{"given":"Caterina","family":"Musolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-8239","authenticated-orcid":false,"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"D\u2019Ascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Avenoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Innao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Gaetano","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"17","key":"3296_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s40265-016-0662-4","volume":"76","author":"S Dhillon","year":"2016","unstructured":"Dhillon S (2016) Zoledronic acid (Reclast<sup>\u00ae<\/sup>, Aclasta<sup>\u00ae<\/sup>): a review in osteoporosis. Drugs 76(17):1683\u20131697","journal-title":"Drugs"},{"key":"3296_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00223-002-2017-2","volume":"72","author":"FP Coxon","year":"2003","unstructured":"Coxon FP, Rogers MJ (2003) The role of prenylated small GTP-binding proteins in the regulation of osteoclast function. Calcif Tissue Int 72:80\u201384","journal-title":"Calcif Tissue Int"},{"key":"3296_CR3","doi-asserted-by":"publisher","first-page":"31461","DOI":"10.18632\/oncotarget.5058","volume":"6","author":"J Kopecka","year":"2015","unstructured":"Kopecka J, Porto S, Lusa S, Gazzano E, Salzano G, Giordano A, Desiderio V, Ghigo D, Caraglia M, De Rosa G, Riganti C (2015) Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells. Oncotarget 6:31461\u201331478. https:\/\/doi.org\/10.18632\/oncotarget.5058","journal-title":"Oncotarget"},{"key":"3296_CR4","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.4161\/cbt.22274","volume":"13","author":"G Misso","year":"2012","unstructured":"Misso G, Porru M, Stoppacciaro A, Castellano M, De Cicco F, Leonetti C, Santini D, Caraglia M (2012) Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. Cancer Biol Ther 13:1491\u20131500","journal-title":"Cancer Biol Ther"},{"key":"3296_CR5","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1182\/blood-2011-01-328526","volume":"118","author":"O Nussbaumer","year":"2011","unstructured":"Nussbaumer O, Gruenbacher G, Gander H, Thurnher M (2011) DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by gammadelta T lymphocytes. Blood 118:2743\u20132751","journal-title":"Blood"},{"key":"3296_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.18632\/oncotarget.1201","volume":"4","author":"E Rietkotter","year":"2013","unstructured":"Rietkotter E, Menck K, Bleckmann A, Farhat K, Schaffrinski M, Schulz M, Hanisch UK, Binder C, Pukrop T (2013) Zoledronic acid inhibits macrophage\/microglia-assisted breast cancer cell invasion. Oncotarget 4:1449\u20131460","journal-title":"Oncotarget"},{"issue":"5","key":"3296_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ctrv.2015.04.007","volume":"41","author":"IS Hamadeh","year":"2015","unstructured":"Hamadeh IS, Ngwa BA, Gong Y (2015) Drug induced osteonecrosis of the jaw. Cancer Treat Rev 41(5):455\u2013464","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"3296_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jcms.2013.05.014","volume":"42","author":"A Allegra","year":"2014","unstructured":"Allegra A, Oteri G, Alonci A, Bacci F, Penna G, Minardi V, Maisano V, Musolino C (2014) Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. J Craniomaxillofac Surg 42(4):279\u2013282","journal-title":"J Craniomaxillofac Surg"},{"key":"3296_CR9","first-page":"2856926","volume":"2016","author":"A Cassoni","year":"2016","unstructured":"Cassoni A, Romeo U, Terenzi V, Della Monaca M, Rajabtork Zadeh O, Raponi I, Fadda MT, Polimeni A, Valentini V (2016) Adalimumab: another medication related to osteonecrosis of the jaws? Case Rep Dent 2016:2856926","journal-title":"Case Rep Dent"},{"issue":"3","key":"3296_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","volume":"35","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) Task force on bisphosphonate-related osteonecrosis of the jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J 35(3):119\u2013130","journal-title":"Aust Endod J"},{"issue":"12","key":"3296_CR11","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.joms.2008.05.369","volume":"67","author":"E Nastro","year":"2009","unstructured":"Nastro E, Allegra A, Oteri G, Ferlito S, Alonci A, Bellomo G, D'Angelo A, Tolomeo A, Cicci\u00f9 D, De Ponte FS, Musolino C (2009) Avascular necrosis of bone in leukemia and osteonecrosis of jaw by bisphosphonates. J Oral Maxillofac Surg 67(12):2701\u20132703","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"3296_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000097876","volume":"117","author":"E Nastro","year":"2007","unstructured":"Nastro E, Musolino C, Allegra A, Oteri G, Cicci\u00f9 M, Alonci A, Quartarone E, Alati C, De Ponte FS (2007) Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. Acta Haematol 117(3):181\u2013187","journal-title":"Acta Haematol"},{"key":"3296_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bone.2009.09.026","volume":"46","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Verrou E (2010) Fatigue in bone: a novel phenomenon attributable to bisphosphonate use. Bone 46:556\u2013558","journal-title":"Bone"},{"key":"3296_CR14","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMc1002684","volume":"363","author":"A Cheung","year":"2010","unstructured":"Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473\u20132474","journal-title":"N Engl J Med"},{"key":"3296_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/01913121003729806","volume":"34","author":"I Perrotta","year":"2010","unstructured":"Perrotta I, Cristofaro MG, Amantea M, Russo E, De Fazio S, Zuccal\u00e0 V, Conforti F, Amorosi A, Donato G, Tripepi S, Giudice M (2010) Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study. Ultrastruct Pathol 34:207\u2013213","journal-title":"Ultrastruct Pathol"},{"key":"3296_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","volume":"136","author":"O Filleul","year":"2010","unstructured":"Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136:1117\u20131124","journal-title":"J Cancer Res Clin Oncol"},{"key":"3296_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bone.2011.07.020","volume":"49","author":"J Cornish","year":"2011","unstructured":"Cornish J, Bava U, Callon KE, Bai J, Naot D, Reid IR (2011) Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells. Bone 49:710\u2013716","journal-title":"Bone"},{"issue":"1","key":"3296_CR18","first-page":"129","volume":"24","author":"E Nastro Siniscalchi","year":"2010","unstructured":"Nastro Siniscalchi E, Cutroneo G, Catalfamo L, Santoro G, Allegra A, Oteri G, Cicci\u00f9 D, Alonci A, Penna G, Musolino C, Saverio De Ponte F, Anastasi G, Favaloro A (2010) Immunohistochemial evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. Oncol Rep 24(1):129\u2013134","journal-title":"Oncol Rep"},{"key":"3296_CR19","first-page":"6538","volume":"62","author":"P Fournier","year":"2002","unstructured":"Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, Cl\u00e9zardin P (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538\u20136544","journal-title":"Cancer Res"},{"key":"3296_CR20","first-page":"2893","volume":"9","author":"D Santini","year":"2003","unstructured":"Santini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F, Gavasci M, Rocci L, Tirindelli MC, Altomare V, Tocchini M, Bonsignori M, Tonini G (2003) Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 9:2893\u20132897","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3296_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000313787","volume":"124","author":"A Allegra","year":"2010","unstructured":"Allegra A, Alonci A, Penna G, Granata A, Nastro Siniscalchi E, Oteri G, Loddo S, Teti D, Cicci\u00f9 D, De Ponte FS, Musolino C (2010) Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws. Acta Haematol 124(2):79\u201385","journal-title":"Acta Haematol"},{"issue":"2","key":"3296_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cyto.2008.05.010","volume":"43","author":"G Oteri","year":"2008","unstructured":"Oteri G, Allegra A, Bellomo G, Alonci A, Nastro E, Penna G, Catalfamo L, Cicci\u00f9 D, De Ponte FS, Musolino C (2008) Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration. Cytokine 43(2):103\u2013104","journal-title":"Cytokine"},{"issue":"9","key":"3296_CR23","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1080\/10428190701509806","volume":"48","author":"A Alonci","year":"2007","unstructured":"Alonci A, Allegra A, Bellomo G, Quartarone E, Oteri G, Nastro E, Cicci\u00f9 D, De Ponte FS, Musolino C (2007) Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. Leuk Lymphoma 48(9):1852\u20131854","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"3296_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hon.819","volume":"25","author":"A Allegra","year":"2007","unstructured":"Allegra A, Oteri G, Nastro E, Alonci A, Bellomo G, Del Fabro V, Quartarone E, Alati C, De Ponte FS, Cicci\u00f9 D, Musolino C (2007) Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. Hematol Oncol 25(4):164\u2013169","journal-title":"Hematol Oncol"},{"issue":"6","key":"3296_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ijom.2011.02.002","volume":"40","author":"J Katz","year":"2011","unstructured":"Katz J, Gong Y, Salmasinia D, Hou W, Burkley B, Ferreira P, Casanova O, Langaee TY, Moreb JS et al (2011) Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. Int J Oral Maxillofac Surg 40(6):605\u2013611","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"3296_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1600-0714.2010.01004.x","volume":"40","author":"PG Arduino","year":"2011","unstructured":"Arduino PG, Menegatti E, Scoletta M, Battaglio C, Mozzati M, Chiecchio A, Berardi D, Vandone AM, Donadio M, Gandolfo S, Scully C, Broccoletti R (2011) Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws. J Oral Pathol Med 40(6):510\u2013515","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"3296_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-2141.2011.08622.x","volume":"154","author":"MT Martino Di","year":"2011","unstructured":"Di Martino MT, Arbitrio M, Guzzi PH, Leone E, Baudi F, Piro E, Prantera T, Cucinotto I, Calimeri T, Rossi M, Veltri P, Cannataro M, Tagliaferri P, Tassone P (2011) A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling. Br J Haematol 154(4):529\u2013533","journal-title":"Br J Haematol"},{"issue":"2","key":"3296_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/bmm.12.14","volume":"6","author":"F Ferla La","year":"2012","unstructured":"La Ferla F, Paolicchi E, Crea F, Cei S, Graziani F, Gabriele M, Danesi R (2012) An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw. Biomark Med 6(2):201\u2013209","journal-title":"Biomark Med"},{"issue":"1","key":"3296_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jcms.2012.10.018","volume":"41","author":"P Stockmann","year":"2013","unstructured":"Stockmann P, Nkenke E, Englbrecht M, Schlittenbauer T, Wehrhan F, Rauh C, Beckmann MW, Fasching PA, Kreusch T, Mackensen A, Wullich B, Schett G, Spriewald BM (2013) Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 41(1):71\u201375","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"3296_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","volume":"17","author":"P Nicoletti","year":"2012","unstructured":"Nicoletti P, Cartsos VM, Palaska PK, Shen Y, Floratos A, Zavras AI (2012) Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3. Oncologist 17(2):279\u2013287","journal-title":"Oncologist"},{"issue":"7","key":"3296_CR31","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","volume":"112","author":"ME Sarasquete","year":"2008","unstructured":"Sarasquete ME, Garc\u00eda-Sanz R, Mar\u00edn L, Alcoceba M, Chill\u00f3n MC, Balanzategui A, Santamaria C, Rosi\u00f1ol L, de la Rubia J, Hernandez MT, Garcia-Navarro I, Lahuerta JJ, Gonz\u00e1lez M, San Miguel JF (2008) Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood 112(7):2709\u20132712","journal-title":"Blood"},{"issue":"6","key":"3296_CR32","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3892\/ijo.2012.1647","volume":"41","author":"A Allegra","year":"2012","unstructured":"Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C (2012) Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 41(6):1897\u20131912","journal-title":"Int J Oncol"},{"key":"3296_CR33","first-page":"33347","volume":"288","author":"T Franceschetti","year":"2013","unstructured":"Franceschetti T, Kessler CB, Lee SK, Delany AM (2013) miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J Cell Biochem 288:33347\u201333360","journal-title":"J Cell Biochem"},{"issue":"7","key":"3296_CR34","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/jcp.24306","volume":"228","author":"M Rossi","year":"2013","unstructured":"Rossi M, Pitari MR, Amodio N, Di Martino MT, Conforti F, Leone E, Botta C, Paolino FM, Del Giudice T, Iuliano E, Caraglia M, Ferrarini M, Giordano A, Tagliaferri P, Tassone P (2013) miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol 228(7):1506\u20131515","journal-title":"J Cell Physiol"},{"key":"3296_CR35","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/ar4282","volume":"15","author":"F Mizoguchi","year":"2013","unstructured":"Mizoguchi F, Murakami Y, Saito T, Miyasaka N, Kohsaka H (2013) miR-31 controls osteoclast formation and bone resorption by targeting RHOA. Arthritis Res Ther 15:R102","journal-title":"Arthritis Res Ther"},{"key":"3296_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15476286.2015.1017205","volume":"12","author":"C Zhao","year":"2015","unstructured":"Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D, Peng J, Wang A, Li Q, Song J, Wang C, Xu X, Xu Z, Zhong G, Han B, Chang YZ, Li Y (2015) miR-214 promotes osteoclastogenesis by targeting pten\/pi3k\/akt pathway. RNA Biol 12:343\u2013353","journal-title":"RNA Biol"},{"key":"3296_CR37","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/jbmr.1845","volume":"28","author":"P Cheng","year":"2013","unstructured":"Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H, Zhu W, Dai RC, Wu XP, Liao EY, Luo XH (2013) miR-148a regulates osteoclastogenesis by targeting v-maf musculo aponeurotic fibrosarcoma oncogene homolog b. J Bone Miner Res 28:1180\u20131190","journal-title":"J Bone Miner Res"},{"key":"3296_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jre.12017","volume":"48","author":"T Kagiya","year":"2013","unstructured":"Kagiya T, Nakamura S (2013) Expression profiling of microRNAs in raw264.7 cells treated with a combination of tumor necrosis factor alpha and rankl during osteoclast differentiation. J Periodontal Res 48:373\u2013385","journal-title":"J Periodontal Res"},{"key":"3296_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/bonekey.2014.44","volume":"3","author":"B Ell","year":"2014","unstructured":"Ell B, Kang Y (2014) MicroRNAs as regulators of bone homeostasis and bone metastasis. Bone Key Rep 3:549. https:\/\/doi.org\/10.1038\/bonekey.2014.44","journal-title":"Bone Key Rep"},{"key":"3296_CR40","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1074\/jbc.M805777200","volume":"284","author":"T Sugatani","year":"2009","unstructured":"Sugatani T, Hruska KA (2009) Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 284:4667\u20134678","journal-title":"J Biol Chem"},{"key":"3296_CR41","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jcb.21335","volume":"101","author":"T Sugatani","year":"2007","unstructured":"Sugatani T, Hruska KA (2007) MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem 101:996\u2013999","journal-title":"J Cell Biochem"},{"key":"3296_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bbagrm.2014.08.002","volume":"1839","author":"C Dou","year":"2014","unstructured":"Dou C, Zhang C, Kang F, Yang X, Jiang H, Bai Y, Xiang J, Xu J, Dong S (2014) miR-7b directly targets dc-stamp causing suppression of nfatc1 and c-fos signaling during osteoclast fusion and differentiation. Biochim Biophys Acta 1839:1084\u20131096","journal-title":"Biochim Biophys Acta"},{"key":"3296_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13375","volume":"512","author":"JY Krzeszinski","year":"2014","unstructured":"Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, Xie XJ, He L, Mangala LS, Lopez-Berestein G, Sood AK, Mendell JT, Wan Y (2014) miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and tgif2. Nature 512:431\u2013435","journal-title":"Nature"},{"issue":"6","key":"3296_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/bjh.12828","volume":"165","author":"S Campo","year":"2014","unstructured":"Campo S, Allegra A, D\u2019Ascola A, Alonci A, Scuruchi M, Russo S, Avenoso A, Gerace D, Campo GM, Musolino C (2014) MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma. Br J Haematol 165(6):801\u2013813","journal-title":"Br J Haematol"},{"key":"3296_CR45","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/OTT.S88463","volume":"8","author":"J Sun","year":"2015","unstructured":"Sun J, Wen X, Jin F, Li Y, Hu J, Sun Y (2015) Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma. Oncol Targets Ther 8:2681\u20132688","journal-title":"Oncol Targets Ther"},{"issue":"107","key":"3296_CR46","first-page":"1","volume":"26","author":"C Ge","year":"2017","unstructured":"Ge C, Zhao G, Li B, Li Y, Cawthorn WP, MacDougald OA, Franceschi RT (2017) Genetic inhibition of PPAR\u03b3 S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis. Bone 26(107):1\u20139","journal-title":"Bone"},{"issue":"4","key":"3296_CR47","doi-asserted-by":"publisher","first-page":"e0153174","DOI":"10.1371\/journal.pone.0153174","volume":"11","author":"NS Adapala","year":"2016","unstructured":"Adapala NS, Kim HK (2016) Comprehensive genome-wide transcriptomic analysis of immature articular cartilage following ischemic osteonecrosis of the femoral head in piglets. PLoS One 11(4):e0153174","journal-title":"PLoS One"},{"issue":"3","key":"3296_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bbrc.2015.05.053","volume":"463","author":"T Tashima","year":"2015","unstructured":"Tashima T, Nagatoishi S, Sagara H, Ohnuma S, Tsumoto K (2015) Osteomodulin regulates diameter and alters shape of collagen fibrils. Biochem Biophys Res Commun 463(3):292\u2013296","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3296_CR49","doi-asserted-by":"publisher","first-page":"e0173209","DOI":"10.1371\/journal.pone.0173209","volume":"12","author":"EM Rosset","year":"2017","unstructured":"Rosset EM, Trombetta-eSilva J, Hepfer G, Yao H, Bradshaw AD (2017) SPARC and the N-propeptide of collagen I influence fibroblast proliferation and collagen assembly in the periodontal ligament. PLoS One 12(2):e0173209","journal-title":"PLoS One"},{"issue":"7","key":"3296_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1302\/2046-3758.37.2000231","volume":"3","author":"A Robubi","year":"2014","unstructured":"Robubi A, Berger C, Schmid M, Huber KR, Engel A, Krugluger W (2014) Gene expression profiles induced by growth factors in in vitro cultured osteoblasts. Bone Joint Res 3(7):236\u2013240","journal-title":"Bone Joint Res"},{"issue":"5","key":"3296_CR51","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3892\/or.2012.1995","volume":"28","author":"CK Cai","year":"2012","unstructured":"Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma YL, Ji ZW, Li XX, Han K, Gao J, Qiu XC, Fan QY, Yang TT, Ma BA (2012) miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep 28(5):1764\u20131770","journal-title":"Oncol Rep"},{"key":"3296_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bi901263m","volume":"49","author":"SM Mooney","year":"2010","unstructured":"Mooney SM, Grande JP, Salisbury JL, Janknecht R (2010) Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49:1\u201310","journal-title":"Biochemistry"},{"key":"3296_CR53","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4161\/cc.7.6.5614","volume":"7","author":"VM Stucke","year":"2008","unstructured":"Stucke VM, Gorses D, Hofmann F (2008) DEAD-box RNA helicase p68 is not required for nuclear translocation of beta-catenin in colon cancer cells. Cell Cycle 7:830\u2013832","journal-title":"Cell Cycle"},{"key":"3296_CR54","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","volume":"99","author":"F Zhan","year":"2002","unstructured":"Zhan F, Hardin J, Kordmeiser B, Bumm K, Zheng M, Tian E, Sanderson R, Yang Y, Wilson C, Zangari M, Anaissie E, Morris C, Muwalla F, van Rhee F, Fassas A, Crowley J, Tricot G, Barlogie B, Shaughnessy J Jr (2002) Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99:1745\u20131757","journal-title":"Blood"},{"key":"3296_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bone.2015.12.016","volume":"84","author":"NS Dole","year":"2016","unstructured":"Dole NS, Delany AM (2016) MicroRNA variants as genetic determinants of bone mass. Bone 84:57\u201368","journal-title":"Bone"},{"issue":"Suppl. 2","key":"3296_CR56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ard.62.suppl_2.ii83","volume":"62","author":"EF Wagner","year":"2003","unstructured":"Wagner EF, Matsuo K (2003) Signalling in osteoclasts and the role of Fos\/AP1 proteins. Ann Rheum Dis 62(Suppl. 2):83\u201385","journal-title":"Ann Rheum Dis"},{"key":"3296_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/72855","volume":"24","author":"K Matsuo","year":"2000","unstructured":"Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF (2000) Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 24:184\u2013187","journal-title":"Nat Genet"},{"key":"3296_CR58","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292\u2013304","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3296_CR59","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/(SICI)1097-4652(199812)177:4<636::AID-JCP14>3.0.CO;2-H","volume":"177","author":"S Reddy","year":"1998","unstructured":"Reddy S, Devlin R, Menaa C, Nishimura R, Choi SJ, Dallas M, Yoneda T, Roodman GD (1998) Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption. J Cell Physiol 177(4):636\u2013645","journal-title":"J Cell Physiol"},{"key":"3296_CR60","first-page":"496193","volume":"2013","author":"Z Deng","year":"2013","unstructured":"Deng Z, Niu G, Cai L, Wei R, Zhao X (2013) The prognostic significance of CD44V6, CDH11, and \u03b2-catenin expression in patients with osteosarcoma. Biomed Res Int 2013:496193","journal-title":"Biomed Res Int"},{"key":"3296_CR61","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1038\/emm.2014.43","volume":"46","author":"J Jia","year":"2014","unstructured":"Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu X, Feng Y, Dai Z (2014) MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis. Mol Med 46:e107. https:\/\/doi.org\/10.1038\/emm.2014.43","journal-title":"Mol Med"},{"issue":"8","key":"3296_CR62","doi-asserted-by":"publisher","first-page":"e0182678","DOI":"10.1371\/journal.pone.0182678","volume":"12","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wei QS, Ding WB, Zhang LL, Wang HC, Zhu YJ, He W, Chai YN, Liu YW (2017) Increased microRNA-93-5p inhibits osteogenic differentiation by targeting bone morphogenetic protein-2. PLoS One 12(8):e0182678","journal-title":"PLoS One"},{"key":"3296_CR63","doi-asserted-by":"publisher","first-page":"20046","DOI":"10.1038\/srep20046","volume":"6","author":"HF Yuan","year":"2016","unstructured":"Yuan HF, Christina VR, Guo CA, Chu YW, Liu RH, Yan ZG (2016) Involvement of MicroRNA-210 demethylation in steroid-associated osteonecrosis of the femoral head. Sci Rep 6:20046. https:\/\/doi.org\/10.1038\/srep20046","journal-title":"Sci Rep"},{"key":"3296_CR64","doi-asserted-by":"publisher","first-page":"22599","DOI":"10.1038\/srep22599","volume":"6","author":"C Hao","year":"2016","unstructured":"Hao C, Yang S, Xu W, Shen JK, Ye S, Xianzhe Liu X, Dong Z, Xiao B, Feng Y (2016) MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3. Sci Rep 6:22599. https:\/\/doi.org\/10.1038\/srep22599","journal-title":"Sci Rep"},{"key":"3296_CR65","doi-asserted-by":"crossref","first-page":"29321","DOI":"10.18632\/oncotarget.8722","volume":"20","author":"D Fanale","year":"2016","unstructured":"Fanale D, Amodeo V, Bazan V, Insalaco L, Incorvaia L, Barraco N, Castiglia M, Rizzo S, Santini D, Giordano A, Castorina S, Russo A (2016) Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? Oncotarget 20:29321\u201329332","journal-title":"Oncotarget"},{"key":"3296_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15\u201320. https:\/\/doi.org\/10.1016\/j.cell.2004.12.035","journal-title":"Cell"},{"key":"3296_CR67","doi-asserted-by":"publisher","first-page":"e114627","DOI":"10.1371\/journal.pone.0114627","volume":"9","author":"JF Xu","year":"2014","unstructured":"Xu JF, Yang GH, Pan XH, Zhang SJ, Zhao C, Qiu BS, Gu HF, Hong JF, Cao L, Chen Y, Xia B, Bi Q, Wang YP (2014) Altered microRNA expression profile in exosomes during osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. PLoS One 9:e114627","journal-title":"PLoS One"},{"key":"3296_CR68","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/j.febslet.2014.05.048","volume":"588","author":"S Hwang","year":"2014","unstructured":"Hwang S, Park SK, Lee HY, Kim SW, Lee JS, Choi EK, You D, Kim CS, Suh N (2014) miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 588:2957\u20132963","journal-title":"FEBS Lett"},{"key":"3296_CR69","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.mad.2008.05.004","volume":"129","author":"OC Maes","year":"2008","unstructured":"Maes OC, An J, Sarojini H, Wang E (2008) Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 129:534\u2013541","journal-title":"Mech Ageing Dev"},{"key":"3296_CR70","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"3296_CR71","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1476-4598-9-232","volume":"9","author":"R Chhabra","year":"2010","unstructured":"Chhabra R, Dubey R, Saini N (2010) Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer 9:232","journal-title":"Mol Cancer"},{"key":"3296_CR72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/gm108","volume":"1","author":"E Larsson","year":"2009","unstructured":"Larsson E, Fredlund Fuchs P, Heldin J, Barkefors I, Bondjers C, Genove G, Arrondel C, Gerwins P, Kurschat C, Schermer B, Benzing T, Harvey SJ, Kreuger J, Lindahl P (2009) Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med 1:108","journal-title":"Genome Med"},{"key":"3296_CR73","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1182\/blood-2006-01-012369","volume":"108","author":"L Poliseno","year":"2006","unstructured":"Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108:3068\u20133071. https:\/\/doi.org\/10.1182\/blood-2006-01-012369","journal-title":"Blood"},{"issue":"1","key":"3296_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2011.198","volume":"33","author":"BA Li","year":"2012","unstructured":"Li BA (2012) A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma. Acta Pharmacol Sin 33(1):3\u20134","journal-title":"Acta Pharmacol Sin"},{"key":"3296_CR75","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/jnci\/djq516","volume":"103","author":"M Pazianas","year":"2011","unstructured":"Pazianas M (2011) Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst 103:232\u2013240","journal-title":"J Natl Cancer Inst"},{"key":"3296_CR76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","volume":"144","author":"AJ Roelofs","year":"2009","unstructured":"Roelofs AJ, Jauhiainen M, Monkkonen H, Rogers MJ, Monkkonen J, Thompson K (2009) Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP. Br J Haematol 144:245\u2013250","journal-title":"Br J Haematol"},{"issue":"3","key":"3296_CR77","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00198-016-3807-0","volume":"28","author":"A Kyrgidis","year":"2017","unstructured":"Kyrgidis A, Yavropoulou MP, Lagoudaki R, Andreadis C, Antoniades K, Kouvelas D (2017) Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients. Osteoporos Int 28(3):991\u2013999","journal-title":"Osteoporos Int"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3296-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3296-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:36:01Z","timestamp":1751488561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3296-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3296"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3296-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"23 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}